Lunai Bioworks to voluntarily delist from Nasdaq and deregister after failing minimum equity rule

Lunai Bioworks announced it received a Nasdaq determination and intends to voluntarily delist its shares and deregister. The company failed to comply with Nasdaq Listing Rule 5550(b)(1), which mandates a minimum stockholders' equity of $2.5 million; it reported a stockholders' deficit of approximately $9.02 million in its fiscal 2026 10-K and did not meet alternative continued-listing standards.

Detected & updated continuously · Source: Nebula